Four the Love of Vaccines
The FDA recently received requests to approve a second COVID booster. At the same, it is unsealing documents that were...
Venture Growth is not Healthcare Growth
Growth is a curious thing. We know it when we see it, but we find it hard to replicate. This...
A Fleeting Perception of Data
Data only tells one part of the story when it comes to understanding health policy. The full story is found...
From Healthy Births to Sustainable Management
Researchers have observed that the offspring of mice and other animals derive health benefits from passing through the vagina.
Is Omicron Mother Nature’s Variant?
It spreads efficiently and quickly, it generally causes milder disease than previous variants and it may confer strong protection against...
Pollen Season is Getting Longer and More Intense with Climate Change
Brace yourselves, allergy suffers – new research shows pollen season is going to get a lot longer and more intense...
How College Instructors Can Help Students Take Care of Their Mental Health
In large part because of the pandemic, college leaders have expressed increased concern for the mental health of students.
How Pet Cancer Data Sheds Light on Human Cancers
Domesticated cats and dogs share approximately 85% of the same DNA as humans. And because both have been intimately associated...
A Perfect Post-Pandemic Health System
The pandemic will influence the future of healthcare in many ways. The most important is the growing influence of individual...
Healthcare has Too Much Strategy, Too Little Care
We obsess over clinical efficiency, to where the strategy of healthcare has taken over the art of medicine. But the...
Employer Health Plans Must Adjust to a Hybrid Workforce
Employer health plans have two goals - keep employees happy and productive. As the workforce changes, the way health plans...
Many Ukrainians Face a Future of Psychological Wounds
“Polina came to our bedroom awakened by the sound of explosions. I didn’t know and still don’t know what to...
Videos
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more